BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 17, 2004
View Archived Issues
Isis Pharmaceuticals reports 2003 highlights
Read More
Repligen updates product development programs
Read More
PSD-95 regulates dopamine-mediated synaptic and behavioral plasticity
Read More
Clinical benefits of cholesterol-lowering drugs in patients at high risk of vascular events
Read More
Sun Pharma to acquire Hindustan Antibiotics
Read More
Orthovisc launched for pain due to osteoarthritis of the knee
Read More
Geron and Merix enter coexclusive license agreement for cancer vaccines
Read More
Series B funding supports CareX drug development
Read More
SBIR grant supports Chimerix drug development for multidrug-resistant HIV
Read More
CCR5 antagonists promising candidates against graft rejection
Read More
Clinical benefits of iguratimod in rheumatoid arthritis
Read More
KRN-1493 ameliorates osteitis fibrosa in rats with secondary hyperparathyroidism
Read More
CGS-21680 increases myocardial blood flow in pigs; potential use in myocardial perfusion imaging
Read More
New data on OPC-28326, a selective peripheral vasodilator, reported at Japanese Meeting
Read More
Effects of TS-011 on cerebral blood flow and infarct size in rats
Read More
Enanta claims new bridged erythromycin derivatives with antibacterial activity
Read More
Three series of GSK-3 inhibitors patented by GSK
Read More
New pegylated HIV fusion inhibitors prepared and tested at Roche
Read More
Biomar presents a novel cytotoxic agent isolated from fungal cultures
Read More
New quinazoline-based HIV reverse transcriptase inhibitors described by BMS researchers
Read More
New alphav integrin inhibitors and their use reported by Sigma-Tau
Read More
GenoMed plans West Nile clinical trial
Read More
Additional phase II data from Theratope study
Read More
FDA Advisory Committee sets date to review RSR-13 NDA
Read More
XL-119 receives orphan drug status for bile duct tumors
Read More
European approval for Faslodex
Read More
DevCo completes lexipafant safety study, seeks commercialization partner
Read More
Submission of final section of Onco TCS rolling NDA
Read More
NDA seeks approval of fixed-dose coformulation of Viread and Emtriva
Read More
Avanir discovers orally active small molecules targeting atherosclerosis
Read More
EMEA warns over safety of olanzapine
Read More